000168705 001__ 168705
000168705 005__ 20260217214838.0
000168705 0247_ $$2doi$$a10.1128/IAI.00665-20
000168705 0248_ $$2sideral$$a125849
000168705 037__ $$aART-2021-125849
000168705 041__ $$aeng
000168705 100__ $$aCruellas M.
000168705 245__ $$aHow could antibiotics, probiotics, and corticoids modify microbiota and its influence in cancer immune checkpoint inhibitors: A review
000168705 260__ $$c2021
000168705 5203_ $$aImmunotherapy has become a new paradigm in oncology, improving outcomes for several types of cancer. However, there are some aspects about its management that remain uncertain. One of the key points that needs better understanding is the interaction between immunotherapy and gut microbiome and how modulation of the microbiome might modify the efficacy of immunotherapy. Consequently, the negative impact of systemic antibiotics and corticosteroids on the efficacy of immunotherapy needs to be clarified.
000168705 536__ $$9info:eu-repo/grantAgreement/ES/DGA-FEDER/B29-17R$$9info:eu-repo/grantAgreement/ES/MCIU-AEI/SAF2017-83120-C2-1-R
000168705 540__ $$9info:eu-repo/semantics/closedAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000168705 590__ $$a3.616$$b2021
000168705 591__ $$aINFECTIOUS DISEASES$$b62 / 95 = 0.653$$c2021$$dQ3$$eT2
000168705 591__ $$aIMMUNOLOGY$$b112 / 162 = 0.691$$c2021$$dQ3$$eT3
000168705 592__ $$a1.139$$b2021
000168705 593__ $$aInfectious Diseases$$c2021$$dQ1
000168705 593__ $$aParasitology$$c2021$$dQ1
000168705 593__ $$aMicrobiology$$c2021$$dQ1
000168705 594__ $$a6.5$$b2021
000168705 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000168705 700__ $$aYubero A.
000168705 700__ $$aZapata M.
000168705 700__ $$0(orcid)0000-0001-6928-5516$$aGálvez E.M.
000168705 700__ $$0(orcid)0000-0002-6811-6654$$aGascón M.
000168705 700__ $$aIsla D.
000168705 700__ $$aLastra R.
000168705 700__ $$0(orcid)0000-0003-3043-147X$$aMartínez-Lostao L.$$uUniversidad de Zaragoza
000168705 700__ $$aOzcáriz M.
000168705 700__ $$0(orcid)0000-0003-0154-0730$$aPardo, J.$$uUniversidad de Zaragoza
000168705 700__ $$0(orcid)0000-0002-3888-7036$$aRamírez A.
000168705 700__ $$aSesma A.
000168705 700__ $$0(orcid)0000-0003-3387-0558$$aTorres-Ramón I.
000168705 700__ $$0(orcid)0000-0002-9600-8116$$aPaño, J.R.$$uUniversidad de Zaragoza
000168705 7102_ $$11011$$2566$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Inmunología
000168705 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000168705 773__ $$g89, 9 (2021), [7 pp.]$$pInfect. immun.$$tInfection and immnunity$$x0019-9567
000168705 8564_ $$s211173$$uhttps://zaguan.unizar.es/record/168705/files/texto_completo.pdf$$yVersión publicada
000168705 8564_ $$s2282242$$uhttps://zaguan.unizar.es/record/168705/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000168705 909CO $$ooai:zaguan.unizar.es:168705$$particulos$$pdriver
000168705 951__ $$a2026-02-17-20:13:49
000168705 980__ $$aARTICLE